In the fourth quarter, the Emerging Markets Core Equity Portfolio retreated in absolute terms but outperformed its benchmark, ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

Although this initial study was not intended to measure sensor accuracy, Glucotrack noted that the system performed as ...

Nanox.ARC is an FDA, CE Marked, digital multi-source 3D tomosynthesis imaging system, providing advanced radiographic visualization. Nanox.ARC unlocks significant value for medical practices, ...

United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...

Summit Therapeutics (SMMT) announced a clinical trial collaboration with Pfizer (PFE) to evaluate ivonescimab, an investigational PD-1 / VEGF ...

With A$AP Rocky’s Ray-Ban moments, courtroom style has become a cultural phenomenon, blending law, fashion, and branding into ...

Three of Australia's most successful global life sciences plays have reported increased interim profits – with the promise of ...

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...